A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
Clinical trial NCT05946941 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05946941
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2026-11-18
- Enrollment
- 774
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.